Alcohol and Stress Hormones

Slides:



Advertisements
Similar presentations
The Addicted Synapse Katie Malanson.
Advertisements

CORTICOSTERONE MODULATES ETHANOL WITHDRAWAL- MEDIATED HIPPOCAMPAL DAMAGE: RELATION TO ELEVATED CA 2+ LEVELS PJ Mulholland 1, RL Self 1, BR Harris 2, HJ.
Addiction: Wise: Drug dependence-- cluster of cognitive, behavioral
 incidence  characteristics  causes?  treatments?
Neurotransmitters Many Neurotransmitters (NT) exist: -Dopamine -Adrenaline -Serotonin -Acetylcholine Drugs can either: –Increase the effect of certain.
Drug Addiction. History: Opiate Effects Characteristics of drug addiction: Characteristics of drug addiction: Tolerance: decreased drug effect w/ repeated.
Neurotransmission and the CNS BY PROF. Azza El-Medany.
Neurobehavioral Aspects of Alcohol Consumption
Mechanisms underlying the psychiatric effects of IFN-α, particularly in anhedonia Edith Grosbellet M1 Signalisation cellulaire et Neurosciences Paris XI/ENS.
Neurobiology of drug action and
The Neurobiology of Addiction
Bringing the Full Power of Science to Bear on Bringing the Full Power of Science to Bear on NIDA NATIONAL INSTITUTE ON DRUG ABUSE Drug Abuse & Addiction.
1 Common Features of Addiction Physical versus Psychological Addiction Tolerance: The fact that increasingly large doses of drugs must be taken to achieve.
Neurobiology of drug action and addiction Richard Palmiter Dept Biochemistry.
Copyright Alcohol Medical Scholars Program1 Alcohol: Pharmacology and Neurobiology Vijay A. Ramchandani, Ph.D. Indiana University School of Medicine.
Role of Medications in Recovery and the Prevention of Relapse Mark Publicker, MD FASAM Medical Director, Mercy Recovery Center, Westbrook Maine.
Addiction & Alcoholism. I. Addiction and its Two Key Forms A. Addiction: a condition in which an individual requires the use of a drug or the participation.
Stress and Health (and the brain) Is stress a good thing?
Drug Tolerance Cross Tolerance Metabolic Tolerance
Dr.farahzadi.1391 dr.farahzadi Overview of Methamphetamine Pharmacology.
AMPAKINE Compounds for the Treatment of Rett Syndrome
Copyright © 2007 by The McGraw-Hill Companies, Inc. All rights reserved. Chapter 17 Substance-Related Disorders – Focus on Alcoholism.
Chapter 9 Alcohol Acute effects Mechanisms of action Long-term effects
Outline BB rain Anatomy SS tructures and functions DD isorders caused by lesions CC omparative Anatomy BB rain Function CC ells in the brain.
Terrence D. Walton, MSW, CSAC Pretrial Services Agency for the
Dr Jonathon Arnold Room 211 c Bosch Building Department of Pharmacology
Lynda Sharrett-Field Addiction Therapy-2014 Chicago, USA August 4 - 6, 2014.
Chapter Four Psychopharmacology Version Dated 21 Sep 2009.
Alcohol Dr Alison Battersby.
Multiple Neuronal Systems Thought to be Involved in Nicotine Dependence Frank Vocci, Ph.D. Director Division of Treatment Research and Development National.
Chapter 16 Schizophrenia
Chapter 11 Cocaine Amphetamines –Amphetamine –Methamphetamine –Ephedrine –Cathinone – khat –MDMA – ecstasy Methylphenidate Caffeine Nicotine
Reinforcement & Drug Effects Lesson 15. Operant Conditioning n Acquisition & Maintenance of behavior l important for survival l Response Consequences.
Copyright © 2009 Allyn & Bacon Chemicals That Harm with Pleasure This multimedia product and its contents are protected under copyright law. The following.
Synaptic Transmission
Copyright (c) Allyn & Bacon Chapter 16 Drug Abuse This multimedia product and its contents are protected under copyright law. The following are.
Neuro Unit 5: How do our choices change our brains?
Neurological Disorders Lesson 5.2 How do drugs alter synaptic transmission? Human Brain Rat Brain.
Substance Use Disorders. A maladaptive pattern of substance use leading to clinically significant social, emotional, or occupational impairment or distress.
Outline Brain Anatomy Structures and functions
PSYCHOACTIVE DRUGS Drugs have revolutionized psychiatric treatment since the 1950's. Most psychoactive drugs act stereospecifically on receptors, enzymes,
Stress and Drugs of Abuse An Introduction. I. Drugs of Abuse and Addiction A. Reward, Reinforcement and Motivation 1. addiction: an overwhelming dependence.
Physiology and Behaviour of Withdrawal Syndrome Idrees M, Hussain A, Hyman A, Humphries R & Hughes E. Introduction On administering certain drugs for long.
Drug addiction – learning gone wild? Dr Stuart McLaren MRCPsych. Phase 1 Psychopharmacology module
Long-Term Voluntary Exercise and the Mouse Hypothalamic-Pituitary-Adrenocorticoid Axis: Impact of Concurrent Treatment with the Antidepressant Drug Tianeptine.
The Hypothalamopituitary-adrenal axis and alcohol preference Matthew J. O’Callaghan, Adam P. Croft, Catherine Jacquot, Hillary J. Little Presented by Muharema.
Pharmacotherapy for Alcohol Dependence
Chronic treatment with cannabinoid receptor agonist, CP 55,940, alters GLT1 expression in adolescent rats Introduction Methods Results Selected References.
Central Nervous System Stimulants Constricted Blood Vessels Constricted Blood Vessels Increased Pulse Increased Pulse Increased Blood Pressure Increased.
Physiology and Behaviour of Withdrawal Syndrome Idrees M, Hussain A, Hyman A, Humphries R & Hughes E. Introduction: Chronic administration of certain drugs.
Reward. Reward Psychopharmacology Rewards can be chemical or natural –food, exercise, sex, drugs Transiently or permanently alter neurochemical pathways.
Neurotransmissions in the Central Nervous System.
Samantha Mohammad And Jack Utz
Burns M. Brady, MD, FASAM, FAAFP
Pharmacology of central Neurotransmitters Prof. Yieldez.
GLUCOCORTICOID RECEPTOR INVOLVEMENT IN PAIR BONDING IN FEMALE PRAIRIE VOLES: THE EFFECTS OF ACUTE BLOCKADE AND INTERACTIONS WITH CENTRAL DOPAMINE REWARD.
알코올 의존, 질병의 경과와 항갈망제의 사용 Industry-sponsored lecture 알코올 의존, 질병의 경과와 항갈망제의 사용 Ki, Seon Wan M.D., Ph. D. Incheon St. Mary’s Hospital Incheon, Korea.
1 Addiction to tobacco Robert West University College London November
The Reward Pathway And Addiction
بنام خدا DR.KARIMI. DRUG ABUSE & MENTAL ILLNESS: Progress in Understanding COMORBIDITY DRUG ABUSE & MENTAL ILLNESS: Progress in Understanding COMORBIDITY.
Dopamine system: neuroanatomy
Motivation Not all responses can be explained by
According to the Specification you need to be able to :
Volume 79, Issue 3, Pages (August 2013)
What are the current guidelines for healthy living
Corticotropin-Releasing Factor in the BNST
Neurobiology of Depression
Volume 23, Issue 1, Pages (April 2018)
Presentation transcript:

Alcohol and Stress Hormones Hilary J. Little Institute of Psychiatry, University of London, United Kingdom

Effects of alcohol i) Acute effects ii) Long term effects - dependence iii) Interactions with stress hormones 1

Alcohol Dependence ? Effect on brain Withdrawal Acute actions normal range Tolerance Relapse 2 Time Alcohol intake

Acute effects of alcohol Decreases effects of excitatory transmitters, glutamate and aspartate. - particular effect at NMDA receptors - may be relevant to amnesic actions Increases effects pf GABA – in some neurons 5-HT transmission altered (?mood changes?) 3

Acute effects of alcohol Increases release of endogenous opiates Increases mesolimbic dopamine transmission Activates the hypothalamo-pituitary adrenal system (HPA) 4

2. Compulsion to take drug Drug dependence 1. Withdrawal symptoms 2. Compulsion to take drug 5

The Alcohol Withdrawal Syndrome Anxiety, irritability Tremor, convulsions (can be fatal) Hallucinations, confusion (‘DT’s’) 6

Aims of our experiments i) Neuronal changes during the acute phase of alcohol withdrawal ii) Long term neuronal changes during alcohol abstinence iii) Potential new medication approaches: - glucocorticoid antagonists 7

Clinical evidence for importance of glucocorticoids in alcohol dependence More severe life events (“danger” & “loss”) in years preceding alcohol dependence “High strain” occupations increase risk for alcohol dependence Stressful experiences during abstinence increase likelihood of relapse drinking Stress induces alcohol craving; related to incidence of relapse 8

Cognitive deficits in alcoholics Incidence of cognitive dysfunction in abstinent alcoholics estimated to be 50 to 80% Difficulties in learning new information, retention over long intervals, problems in executive function No current effective treatment 9

Cognitive deficits in alcoholics Neuronal damage after long term alcohol consumption:- frontal association cortex, hippocampus (rodents), thalamus Preclinical and clinical evidence that withdrawal of alcohol after long term consumption plays an important role in memory deficits In high concentrations, glucocorticoid stress hormones (cortisol, corticosterone) cause neurotoxicity and cognitive deficits 10

Stress and drug dependence Stress can alter the effects of many drugs Causes alterations in synaptic plasticity and neuronal survival Such changes include acute, prolonged and delayed effects Stress activates the mesolimbic dopamine system 11

cortisol (or corticosterone) h e H y p o t h a l a m i c - P i t u i t a r y - A d r e n a l A x i s The HPA axis `C R F P I T U I T A R Y ACTH a d r e n a l s cortisol (or corticosterone) 12

Corticosterone in the brain Type I (mineralocorticoid) receptors Type II glucocorticoid receptors What effects does corticosterone have on the brain during alcohol withdrawal? What are the concentrations of corticosterone in the brain? Why do the concentrations matter? 13

VTA Mesolimbic dopamine system nucleus accumben DA Initial target sites differ, but some common neuronal actions e.g dopamine release Mesolimbic dopamine pathway activated by natural rewards This pathway also activated by stress NMDA activation nucleus accumben VTA DA Alcohol, nicotine, opiates Cocaine, amphetamine 14

Effect of corticosterone on firing of ventral tegmental neurones from control animals Firing rate (Hz) 1 2 3 4 * ** Basal firing 5 µM NMDA 15 µM NMDA aCSF Corticosterone 100 nM *P < 0.05 **P < 0.01 15

Corticosterone concentrations in rodent brain Measured corticosterone concentrations in brain regions in rodents after chronic alcohol consumption Chronic alcohol treatment and withdrawal Radioimmunoassay after ethanol/DMSO extraction of brain homogenates Identity of corticosterone verified by HPLC and GC-MS 16

Regional brain concentrations of corticosterone C57 strain mice Alcohol drinking for 20 weeks Samples 6 days after withdrawal Corticosterone ng/g ** * 300 250 50 100 150 Blood corticosterone, nM Total Free 200 150 100 50 Hypoth. Hipp. Brain PFC Cortex Striat. Thal. Cereb. stem When alcohol not withdrawn, no changes in brain corticosterone 17

Regional brain corticosterone concentrations Lister Hooded rats, 8 months drinking, 2 months abstinence 10 20 30 * Chronic alcohol Corticosterone ng/g Hypoth Hipp Midbrain PFC Cortex Striatum Plasma concentrations not significantly different Controls 18

Summary: brain corticosterone and alcohol Chronic alcohol consumption increased brain concentrations of the glucocorticoid, corticosterone Plasma levels unchanged Changes seen only after alcohol withdrawal Largest increases in prefrontal cortex and hippocampus 20

Mechanism of brain corticosterone changes after chronic alcohol treatment and withdrawal? Local synthesis of glucocorticoids suggested to occur outside adrenal glands Demonstrated in adipose tissue Occurs via the enzyme 11--hydroxysteroid dehydrogenase (HSD-1) This enzyme is present in brain 20

Relevance of brain glucocorticoid changes? i) Involved in alcohol-induced brain damage? ii) Responsible for cognitive deficits after long term alcohol intake? iii) Alter feedback mechanisms for control of adrenal hormone release? iv) Involved in continued desire to drink alcohol? 21

Current drug treatments for alcohol dependence Naltrexone Opiate antagonist Decreases continuation of drinking once relapse occurs Acamprosate Mechanism unknown Sole action apparently to decrease alcohol intake Disulphiram (“Antabuse”) Prevents metabolism of acetaldehyde this accumulates, producing unpleasant symptoms. - may help those who really want to stop drinking Effects: 10 – 20% decrease in relapse drinking 22

Alcohol withdrawal = window of opportunity? normal range Withdrawal ? Relapse Time Effect on brain Alcohol intake 23

Alcohol withdrawal = window of opportunity? Multiple withdrawal episodes, more severe withdrawal, higher risk of relapse, greater cognitive deficits Evidence cognitive deficits due to withdrawal rather than to direct effects Acute withdrawal phase offers "window of opportunity" for treatment Drug studied:- i) glucocorticoid Type II receptor antagonist – "mifepristone" 25

Effects of Mifepristone on Alcohol Withdrawal Hyperexcitability in Mice Vehicle/alcohol withdrawal Median response score Vehicle/control 3 weeks alcohol via liquid diet Mifepristone /alcohol withdrawal Mifepristone/control 1 2 3 4 Injections of vehicle or mifepristone just prior to withdrawal Response to handling measured 3 4 5 6 7 8 9 Time (h) Mifepristone, the Type II glucocorticoid receptor antagonist decreased, but did not prevent, alcohol withdrawal hyperexcitability 25

Object recognition test 26

Effects of Mifepristone on Memory Deficit in Mice after Alcohol Withdrawal - Object Recognition Test Vehicle/control 22 weeks alcohol via drinking fluid Vehicle/alcohol withdrawal Mifepristone /alcohol withdrawal Mifepristone/control * Injections of vehicle or mifepristone just prior to withdrawal -0.1 0.0 0.1 0.2 0.3 0.4 0.5 Difference in time measured between exploration of novel and familiar objects, 1 week after withdrawal Mifepristone decreased the memory loss seen after withdrawal from chronic alcohol intake 27

Effects of Mifepristone on Neuronal Damage in Organotypic Hippocampal Cultures 20X 5X Propidium iodide fluorescence Control Alcohol withdrawal Corticosterone + alcohol withdrawal Mifepristone + corticosterone + alcohol withdrawal Spironolactone + corticosterone + alcohol withdrawal Corticosterone greatly increased the neuronal damage caused by withdrawal of alcohol. Mifepristone, but not spironolactone prevented this effect of corticosterone 28 Collaboration with University of Kentucky

Effects of Type II glucocorticoid receptor antagonist mifepristone (RU38486) on alcohol preference in mice Alcohol preference ratio Low alcohol preferring mice Saline injections Mifepristone injections 0.0 0.1 0.2 0.3 0.4 0.5 0.6 Choice 8% alcohol v tap water Once daily injections of isotonic saline or Type II receptor antagonist === === === *** *** *** 2 4 6 8 10 12 14 16 18 20 Day Slowly developing increase in alcohol preference and consumption Effect prevented by mifepristone 29

Clinical Trial of Mifepristone in Alcoholics Participants - alcoholics entering the Alcohol Unit for detoxification Treatment - mifepristone or placebo for two weeks from cessation of drinking Testing – depression ratings and cognitive test battery (CANTAB) during weeks 3 and 4 Follow-up – 3,6 and 12 months to record relapse drinking 30

Mifepristone as a Potential Treatment? Glucocorticoid Type II receptor antagonist e.g. mifepristone Reduced withdrawal severity Reduced memory loss Prevented neurotoxicity in vitro Prevent stress-induced increases in alcohol drinking ?effective in alcoholics - study in progress 32

Future treatments for drug dependence? Little research on drug dependence was supported by government funding 1990s Drug dependence becomes a special target area for research 2000s Possibility accepted of medication treatment for alcohol dependence Next? ? Development of effective treatments to prevent dependence and memory loss?